Vertex Pharmaceuticals Incorporated
Utility Patents

Last updated:

List of all Vertex Pharmaceuticals Incorporated patents 9 in total

Status Patent
Grant
Utility: Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator External link
Filling date: 17 Oct 2025 Issue date: 27 Sep 2022
Grant
Utility: Antiproliferation compounds and uses thereof External link
Filling date: 17 Oct 2025 Issue date: 13 Sep 2022
Grant
Utility: Processes for preparing pyrrolidine compounds External link
Filling date: 17 Oct 2025 Issue date: 6 Sep 2022
Grant
Utility: Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders External link
Filling date: 17 Oct 2025 Issue date: 30 Aug 2022
Grant
Utility: Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator External link
Filling date: 17 Oct 2025 Issue date: 16 Aug 2022
Grant
Utility: Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 External link
Filling date: 17 Oct 2025 Issue date: 19 Jul 2022
Grant
Utility: Materials and methods for treatment of Duchenne Muscular Dystrophy External link
Filling date: 17 Oct 2025 Issue date: 28 Jun 2022
Grant
Utility: Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels External link
Filling date: 17 Oct 2025 Issue date: 14 Jun 2022
Grant
Utility: Inhibitors of influenza viruses replication External link
Filling date: 17 Oct 2025 Issue date: 29 Dec 2020

Showing 1 to 9 of 9 patents.